Literature DB >> 31032092

Racial disparities in the incidence of colon cancer in patients with inflammatory bowel disease.

Priyanka Vij1, Debbie Chen1, Chiu-Hsieh Hsu2, Viraj Pandit1, Pamela Omesiete1, Emad Elquza1, Aaron Scott1, Alejandro Cruz1, Valentine Nfonsam1.   

Abstract

BACKGROUND: Studies have explored the relationship between inflammatory bowel disease (IBD) [ulcerative colitis (UC) and Crohn's disease (CD)] and colon cancer (CC). Additionally, racial disparities in the incidence of CC is well known. However, the impact of racial disparity in IBD patients who develop CC remains unclear. The aim of this study is to address the knowledge gap in this particular group of patients.
METHODS: A retrospective analysis was done using the National Inpatient Sample (NIS) database from 2011. We included patients with IBD over age ≥18 years with a diagnosis of CC. Patients were stratified by race, gender, age, presence of IBD and CC. Statistical analysis was performed to compare the groups.
RESULTS: A total of 57,542 patients were included (CD: 36,357, UC: 21,001). Of all patients with and without IBD, advanced age, Black and Asian race conferred an increased risk of developing CC, whereas female gender, Hispanic and Native American race conferred a protective effect. In patients with IBD, advanced age conferred an increased risk for developing CC while female gender conferred a protective effect. In this subset of patients, black race conferred a protective effect.
CONCLUSIONS: Racial disparity exists in the overall incidence of CC and among patients with IBD who develop CC. Interestingly, black race conferred a protective effect for patients with IBD, contrary to what is seen in the general population. These findings could be attributed to the environmental factors and genetic makeup between racial groups. Further studies are warranted to better understand these disparities.

Entities:  

Keywords:  Inflammatory bowel disease (IBD); colon cancer (CC); racial disparity

Year:  2019        PMID: 31032092      PMCID: PMC6465509          DOI: 10.21037/jgo.2019.01.06

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  26 in total

1.  Diet and inflammatory bowel disease: a case-control study.

Authors:  P G Persson; A Ahlbom; G Hellers
Journal:  Epidemiology       Date:  1992-01       Impact factor: 4.822

2.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

3.  Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan.

Authors:  Naomasa Sakamoto; Suminori Kono; Kenji Wakai; Yoshihiro Fukuda; Masamichi Satomi; Takashi Shimoyama; Yutaka Inaba; Yoshihiro Miyake; Satoshi Sasaki; Kazushi Okamoto; Gen Kobashi; Masakazu Washio; Tetsuji Yokoyama; Chigusa Date; Heizo Tanaka
Journal:  Inflamm Bowel Dis       Date:  2005-02       Impact factor: 5.325

Review 4.  Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.

Authors:  Stephen B Hanauer
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

5.  Inflammatory bowel disease in spouses and their offspring.

Authors:  D Laharie; S Debeugny; M Peeters; A Van Gossum; C Gower-Rousseau; J Bélaïche; R Fiasse; J L Dupas; E Lerebours; S Piotte; A Cortot; S Vermeire; B Grandbastien; J F Colombel
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

6.  Cancer risk in patients with inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; E Kliewer; A Wajda
Journal:  Cancer       Date:  2001-02-15       Impact factor: 6.860

7.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 8.  Intestinal inflammation and cancer.

Authors:  Thomas A Ullman; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

9.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.

Authors:  Tine Jess; Edward V Loftus; Fernando S Velayos; W Scott Harmsen; Alan R Zinsmeister; Thomas C Smyrk; Cathy D Schleck; William J Tremaine; L Joseph Melton; Pia Munkholm; William J Sandborn
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

10.  Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

Authors:  Sverre Söderlund; Fredrik Granath; Olle Broström; Per Karlén; Robert Löfberg; Anders Ekbom; Johan Askling
Journal:  Gastroenterology       Date:  2010-02-16       Impact factor: 22.682

View more
  1 in total

1.  A comparison of the efficacy and safety of complementary and alternative therapies for ulcerative colitis: A protocol for systematic review and meta-analysis.

Authors:  Meiqi Lu; Ting Zhang; Zhen Lu; Wei Wang; Ting Chen; Zhiqun Cao
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.